Establishment of hypoglycemic agent screening method based on human glucokinase

Biomed Environ Sci. 2009 Feb;22(1):62-9. doi: 10.1016/S0895-3988(09)60024-6.

Abstract

Objective: To establish a reliable platform for screening glucokinase activators (GKAs) in vitro.

Methods: Pancreatic glucokinase (PGK) protein expressed in a prokaryotic expression system as a histidine-tagged fusion protein from Homo sapiens was produced. Then, response surface methodology (RSM) was used to optimize the microplate-based GKA screening platform. In the first step of optimization with Plackett-Burman design (PBD), initial pH, reaction time and MgCl2 were found to be important factors affecting the activity ratio of GKA (RO-28-1675) significantly. In the second step, a 2(3) full factorial central composite design (CCD) and RSM were applied to the optimal condition determination of each significant variable. A second-order polynomial was determined by a multiple regression analysis of the experimental data.

Results: The following optimal values for the critical factors were obtained: initial pH 0 (7.0), reaction time-0.63 (13.7 min) and MgCl2 0.11 (2.11 mmol/L) with a predicted value of the maximum activity ratio of 34.1%.

Conclusion: Under the optimal conditions, the practical activity ratio is 34.8%. The determination coefficient (R2) is 0.9442, ensuring adequate credibility of the model. LLAE3, extracted from Folium nelumbinis in our laboratory, has prominently activated effects on PGK.

Publication types

  • Evaluation Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analysis of Variance
  • Drug Discovery / methods*
  • Enzyme Activators / analysis*
  • Escherichia coli / genetics
  • Genetic Vectors
  • Glucokinase / metabolism*
  • Humans
  • Hydrogen-Ion Concentration
  • Hypoglycemic Agents / analysis*
  • Kinetics
  • Time Factors

Substances

  • Enzyme Activators
  • Hypoglycemic Agents
  • Glucokinase